Adaptive Biotechnologies
ADPT
ADPT
200 hedge funds and large institutions have $709M invested in Adaptive Biotechnologies in 2023 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 58 increasing their positions, 73 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
8% less capital invested
Capital invested by funds: $769M → $709M (-$60.8M)
21% less repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 73
32% less call options, than puts
Call options by funds: $482K | Put options by funds: $710K
Holders
200
Holding in Top 10
1
Calls
$482K
Puts
$710K
Top Buyers
| 1 | +$14M | |
| 2 | +$7.27M | |
| 3 | +$6.36M | |
| 4 |
Aberdeen Group
Edinburgh,
United Kingdom
|
+$4.58M |
| 5 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$3.1M |
Top Sellers
| 1 | -$9.75M | |
| 2 | -$5.83M | |
| 3 | -$4.38M | |
| 4 |
Principal Financial Group
Des Moines,
Iowa
|
-$3.7M |
| 5 |
BWLSA
Blue Water Life Science Advisors
Larkspur,
California
|
-$3.38M |